Добавить новость
ru24.net
World News in Dutch
Ноябрь
2016

3 arthritis pain drugs prove equally safe for the heart

NEW ORLEANS (AP) — A new study gives some reassurance to arthritis sufferers who want pain relief but are worried about side effects.

Some other doctors were less confident, partly because follow-up information was missing on one-fourth of the participants, and many others stopped taking their assigned drug.

The study tested daily use of Celebrex versus prescription-strength ibuprofen or naproxen in 24,000 arthritis patients with heart disease or a risk factor for it such as diabetes.

The results only apply to these drugs and amounts — not to occasional use of lower, over-the-counter doses (ibuprofen is sold as Motrin, Advil and other brands; naproxen is sold as Naprosyn and Aleve), or to other painkillers such as Tylenol.

After more than two years in the study, about 2 percent of participants had suffered a heart attack, stroke, heart-related death or other heart problem regardless of what drug they were taking.

The study was not designed to compare the drugs for pain relief, but naproxen showed a small advantage on one measure of that over Celebrex.

The study was aimed at people at high heart risk, yet only 20 percent of participants already had heart disease; the rest just had risk factors.

[...] people on ibuprofen or naproxen had more room to escalate their doses than those on Celebrex did because that drug's label limits it to what is considered safe now.




Moscow.media
Частные объявления сегодня





Rss.plus
















Музыкальные новости




























Спорт в России и мире

Новости спорта


Новости тенниса